SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-059353
Filing Date
2018-11-13
Accepted
2018-11-13 16:06:29
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv506096_10q.htm 10-Q 321635
2 EXHIBIT 31.1 tv506096_ex31-1.htm EX-31.1 10860
3 EXHIBIT 31.2 tv506096_ex31-2.htm EX-31.2 11034
4 EXHIBIT 32.1 tv506096_ex32-1.htm EX-32.1 3827
5 EXHIBIT 32.2 tv506096_ex32-2.htm EX-32.2 3687
6 GRAPHIC tv506096_img1.jpg GRAPHIC 7812
7 GRAPHIC tv506096_img2.jpg GRAPHIC 395098
  Complete submission text file 0001144204-18-059353.txt   4198133

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mrkr-20180930.xml EX-101.INS 1072496
9 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20180930.xsd EX-101.SCH 30493
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrkr-20180930_cal.xml EX-101.CAL 15684
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrkr-20180930_def.xml EX-101.DEF 182117
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20180930_lab.xml EX-101.LAB 206154
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20180930_pre.xml EX-101.PRE 204115
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 181177954
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1